Benazepril
Benazepril is a pharmaceutical drug with 10 clinical trials. Historical success rate of 70.0%.
Success Metrics
Based on 7 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
0
Mid Stage
5
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
70.0%
7 of 10 finished
30.0%
3 ended early
0
trials recruiting
10
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Preventing Microalbuminuria in Type 2 Diabetes
Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
Clinical Trials (10)
Preventing Microalbuminuria in Type 2 Diabetes
Preventing ESRD in Overt Nephropathy of Type 2 Diabetes
Safety of Dual Blockage of Rennin-angiotensin System in Patients With Advanced Renal Insufficiency
Comparison Between Losartan and Benazepril in Diabetic Hypertensive Patients Not Controlled by Amlodipine
Renal Protective Effects of Renin Angiotensin System (RAS) Inhibitor in Peritoneal Dialysis Patients
Supramaximal Titrated Inhibition of RAAS in Dilated Cardiomyopathy
Low Dose Versus Aggressive Inhibition of the Renin-Angiotensin-Aldosterone (RAS) to Treat Microalbuminuria
Treatment of High Blood Pressure Using Olmesartan With Hydrochlorothiazide Compared to an ACE Inhibitor With a Calcium Channel Blocker
Long-Term Renoprotection of Optimal Antiproteinuric Doses of Benazepril and Losartan in Chronic Renal Insufficiency
Benazepril for Advanced Chronic Renal Insufficiency
All 10 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 10